FDA Approved: NGENLA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for NGENLA (somatrogon-GHLA) submitted by Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• NGENLA (SOMATROGON-GHLA)

Snippet

SUPPL AP for NGENLA (SOMATROGON-GHLA)